Literature DB >> 29344070

Diffuse Colour Discrimination as Marker of Afferent Visual System Dysfunction in Amyotrophic Lateral Sclerosis.

Lindsay Boven1, Qin Li Jiang2, Heather E Moss3.   

Abstract

Abnormalities of the inner and intermediate retinal structures in patients with amyotrophic lateral sclerosis (ALS) have been described using optical coherence tomography and histopathology. Colour vision is a potential marker of these structural changes. The purpose of this study is to test the hypothesis that colour vision impairment is associated with ALS. Monocular (right eye) colour vision was assessed in subjects with definite or probable ALS (n = 25, aged 50-80 years) and control (n = 21, aged 46-89 years) subjects with corrected near visual acuity of at least 20/40 using the L'Anthony D15 color test (desaturated), scored by c-index, a measure of diffuse colour discrimination. Of ALS subjects, 16/25 (64%) had impaired colour vision (c-index >1.8). Comparing with our normal subjects and accounting for age, 72% (n = 18) of ALS subjects had colour vision below the 50th percentile, 52% (n = 13) had colour vision below the 25th percentile, 24% (n = 6) had colour vision below the 10th percentile, and 8% (n = 2) had colour vision below the 2nd percentile. In multivariate models of ln(c-index) and age, the intercept was higher and the slope was flatter in ALS subjects, suggesting that colour vision deficits are more prominent in younger ALS patients. Diffuse colour discrimination deficits are detected in ALS subjects at younger ages than in control subjects. Further study is needed to confirm these findings and to determine if the ALS colour discrimination abnormalities correlate with structural markers of retinal involvement and ALS disease severity.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; colour vision; desaturated L’Anthony D-15; retinal disease

Year:  2017        PMID: 29344070      PMCID: PMC5764062          DOI: 10.1080/01658107.2017.1326153

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  15 in total

1.  Decreased color discrimination and contrast sensitivity in Parkinson's disease.

Authors:  V Pieri; N J Diederich; R Raman; C G Goetz
Journal:  J Neurol Sci       Date:  2000-01-01       Impact factor: 3.181

2.  Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation.

Authors:  Amani A Fawzi; Joseph M Simonett; Patryk Purta; Heather E Moss; Jessica L Lowry; Han-Xiang Deng; Nailah Siddique; Robert Sufit; Eileen H Bigio; Nicholas J Volpe; Teepu Siddique
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-16       Impact factor: 4.092

3.  A quantitative scoring technique for panel tests of color vision.

Authors:  A J Vingrys; P E King-Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-01       Impact factor: 4.799

4.  Colour vision impairment is associated with disease severity in multiple sclerosis.

Authors:  Elena H Martínez-Lapiscina; Santiago Ortiz-Pérez; Elena Fraga-Pumar; Eloy Martínez-Heras; Iñigo Gabilondo; Sara Llufriu; Santiago Bullich; Marc Figueras; Albert Saiz; Bernardo Sánchez-Dalmau; Pablo Villoslada
Journal:  Mult Scler       Date:  2014-01-07       Impact factor: 6.312

5.  Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.

Authors:  M L Baier; G R Cutter; R A Rudick; D Miller; J A Cohen; B Weinstock-Guttman; M Mass; L J Balcer
Journal:  Neurology       Date:  2005-03-22       Impact factor: 9.910

6.  Clinical color vision testing and correlation with visual function.

Authors:  Jiawei Zhao; Sarita B Davé; Jiangxia Wang; Prem S Subramanian
Journal:  Am J Ophthalmol       Date:  2015-06-24       Impact factor: 5.258

7.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

8.  High and Low Contrast Visual Acuity Are Not Affected in Amyotrophic Lateral Sclerosis.

Authors:  Heather E Moss; Monica Samelson; Girish Mohan; Qin Li Jiang
Journal:  PLoS One       Date:  2016-12-29       Impact factor: 3.240

9.  Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.

Authors:  Fatih C Gundogan; Ahmet Tas; Salih Altun; Oguzhan Oz; Uzeyir Erdem; Gungor Sobaci
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

10.  Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis.

Authors:  Joseph M Simonett; Russell Huang; Nailah Siddique; Sina Farsiu; Teepu Siddique; Nicholas J Volpe; Amani A Fawzi
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more
  2 in total

Review 1.  Human visual skills for brain-computer interface use: a tutorial.

Authors:  Melanie Fried-Oken; Michelle Kinsella; Betts Peters; Brandon Eddy; Bruce Wojciechowski
Journal:  Disabil Rehabil Assist Technol       Date:  2020-06-01

2.  Workshops of the Seventh International Brain-Computer Interface Meeting: Not Getting Lost in Translation.

Authors:  Jane E Huggins; Christoph Guger; Erik Aarnoutse; Brendan Allison; Charles W Anderson; Steven Bedrick; Walter Besio; Ricardo Chavarriaga; Jennifer L Collinger; An H Do; Christian Herff; Matthias Hohmann; Michelle Kinsella; Kyuhwa Lee; Fabien Lotte; Gernot Müller-Putz; Anton Nijholt; Elmar Pels; Betts Peters; Felix Putze; Rüdiger Rupp; Gerwin Schalk; Stephanie Scott; Michael Tangermann; Paul Tubig; Thorsten Zander
Journal:  Brain Comput Interfaces (Abingdon)       Date:  2019-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.